Article summarizing congressional committee meeting.
Video (2h15m): https://www.hsgac.senate.gov/hearings/origins-of-covid-19-an-examination-of-available-evidence/
Steven Quay is the CEO of Atossa Therapeutics, Inc., and a former facculty member at the Stanford University School of Medicine.
Richard Enbright a professor of chemistry and lab director at the Waksman Institute of Microbiology at Rutgers University.
"Quay — who began by telling the committee he was speaking “as an independent scientist” with no relevant financial ties — explained that the genome of SARS-CoV-2 has seven features that would be expected to be found in a virus constructed in a laboratory and which are not found in viruses from nature.
'The statistical probability of finding each feature in nature can be determined,' Quay said, 'and the combined probability that SARS2 came from nature is less than one in a billion.'
Ebright said his extensive research and gathering of documents likewise pointed toward a lab leak."
© 2016 - 2024 Children's Health Defense® • All Rights Reserved